The mRNA-Based Therapy Landscape

The attention on mRNA-based therapies has continuously increased over the past decade, with a surge coming as a result of the mRNA-based COVID-19 vaccine success. With mRNA therapeutics continuing to grow beyond COVID-19, it is hard to keep track of this booming landscape.

Due to the current focus on their activity and potential, and in partnership with the mRNA-Based Therapeutics Summit, our Beacon RNA team have created an infographic of the landscape so far.

mRNA-Based Therapy Landscape Infographic

Here are some of the key highlights covered in the infographic.

  • Current Status of mRNA-Based Therapies
  • Top Drug Developers in the mRNA Space
  • mRNA Therapies by Number of Trials and Trials Initiation
  • Top Disease Indications Across Non-Oncology & Oncology Landscapes
  • Top Delivery Systems Across the mRNA Landscape

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search